S&P 500   5,064.69 (-1.15%)
DOW   37,720.15 (-0.69%)
QQQ   431.48 (-1.55%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
S&P 500   5,064.69 (-1.15%)
DOW   37,720.15 (-0.69%)
QQQ   431.48 (-1.55%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
S&P 500   5,064.69 (-1.15%)
DOW   37,720.15 (-0.69%)
QQQ   431.48 (-1.55%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)
S&P 500   5,064.69 (-1.15%)
DOW   37,720.15 (-0.69%)
QQQ   431.48 (-1.55%)
AAPL   172.71 (-2.18%)
MSFT   414.50 (-1.75%)
META   498.66 (-2.59%)
GOOGL   155.25 (-1.57%)
AMZN   183.74 (-1.28%)
TSLA   162.91 (-4.76%)
NVDA   867.59 (-1.62%)
AMD   159.90 (-2.07%)
NIO   3.86 (-6.08%)
BABA   70.60 (-0.97%)
T   16.20 (-0.67%)
F   12.28 (-2.62%)
MU   121.35 (-0.95%)
GE   153.20 (-0.92%)
CGC   7.04 (-9.74%)
DIS   113.32 (-0.61%)
AMC   2.54 (-4.15%)
PFE   25.93 (+0.27%)
PYPL   63.71 (-1.36%)
XOM   119.54 (-0.69%)

Immunome (IMNM) Earnings Date, Estimates & Call Transcripts

$19.41
-1.17 (-5.69%)
(As of 02:15 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

IMNM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IMNM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Immunome Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($1.63)($0.52)($1.08)
Q2 20242($0.53)($0.18)($0.36)
Q3 20242($0.60)($0.21)($0.41)
Q4 20242($0.63)($0.25)($0.44)
FY 20248($3.39)($1.16)($2.28)
Q1 20251($0.78)($0.78)($0.78)
Q2 20251($0.75)($0.75)($0.75)
Q3 20251($0.78)($0.78)($0.78)
Q4 20251($0.80)($0.80)($0.80)
FY 20254($3.11)($3.11)($3.11)

IMNM Earnings Date and Information

Immunome has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 3rd, 2024 based off prior year's report dates.

Immunome Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/3/2024
Estimated)
------- 
11/9/2023Q3 2023-($0.36)($0.36)($0.36)-$3.57 million
8/9/2023Q2 2023-($0.46)($0.46)($0.46)-$4.26 million
5/5/2023Q1 2023-($0.35)($0.35)($0.35)-$2.36 million
3/16/2023Q4 2022-($0.64)($0.64)($0.64)--
11/14/2022Q3 2022-($0.75)($0.75)($0.75)--
8/5/2022Q2 2022-($0.74)($0.74)($0.74)--
5/12/2022Q1 2022-($0.96)($0.96)($0.96)--    
3/28/2022Q4 2021-($0.66)($0.66)($0.66)--
11/15/2021Q3 2021($0.51)($0.65)($0.14)($0.65)--
8/16/2021Q2 2021-($0.46)($0.46)($0.46)--
5/12/2021Q1($0.41)($0.37)+$0.04($0.37)--

Immunome Earnings - Frequently Asked Questions

When is Immunome's earnings date?

Immunome has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 3rd, 2024 based off last year's report dates. Learn more on IMNM's earnings history.

How much revenue does Immunome generate each year?

Immunome (NASDAQ:IMNM) has a recorded annual revenue of $14.02 million.

How much profit does Immunome generate each year?

Immunome (NASDAQ:IMNM) has a recorded net income of -$106.81 million. IMNM has generated -$5.39 earnings per share over the last four quarters.

What is Immunome's EPS forecast for next year?

Immunome's earnings are expected to decrease from ($1.91) per share to ($2.36) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:IMNM) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners